OCUL
Ocular Therapeutix, Inc.Healthcare$8.49
▲ Bullish
Mkt Cap: $1.85B|Float: 215.4M|SI: 11.0%|DTC: 2.5
Data as of market close Apr 2, 2026
IV Rank
95
IV Pctl
78%
HV 20d
52.2%
52W Range
$6-$16
ATR(14)
$0.46
Exp. Move
±9.4%
P/C Ratio
0.58
Earnings
May 5
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
Low Put/Call
OCUL Key Options Data
- IV Rank
- 94.9%
- Total GEX
- $0.00B
- Total DEX
- $2.4M
- Max Pain
- $4.00
- Expected Move
- ±9.4%
- Put/Call OI
- 0.58
- Net Premium
- $0.1M
- Spot Price
- $8.49
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$0.80 | ±9.4% | $7.69 | $9.29 |
| 2026-04-17 | 15 | ±$0.62 | ±7.4% | $7.86 | $9.11 |
| 2026-04-24 | 22 | ±$0.75 | ±8.8% | $7.74 | $9.24 |
| 2026-05-01 | 29 | ±$1.50 | ±17.7% | $6.99 | $9.99 |
| 2026-05-15 | 43 | ±$4.90 | ±57.7% | $3.59 | $13.39 |
| 2026-06-18 | 77 | ±$3.40 | ±40.0% | $5.09 | $11.89 |
Explore OCUL options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.